May 2008
Volume 49, Issue 13
ARVO Annual Meeting Abstract  |   May 2008
MMP-9 Regulation in Corneal Epithelial Cells
Author Affiliations & Notes
  • G. M. Gordon
    Cell Biology/Anatomy, Bascom Palmer Eye Ins/Univ Miami, Miami, Florida
  • D. R. Ledee
    Cell Biology/Anatomy, Bascom Palmer Eye Ins/Univ Miami, Miami, Florida
  • M. E. Fini
    Cell Biology/Anatomy, Bascom Palmer Eye Ins/Univ Miami, Miami, Florida
  • Footnotes
    Commercial Relationships  G.M. Gordon, None; D.R. Ledee, None; M.E. Fini, None.
  • Footnotes
    Support  R01-EY12651, P30-EY014801, Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3377. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G. M. Gordon, D. R. Ledee, M. E. Fini; MMP-9 Regulation in Corneal Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3377. doi:

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : The critical role of MMP-9 in corneal wound healing is well established, therefore understanding the mechanisms regulating MMP-9 is important. Potential regulatory stimuli range from circulating salt, glucose or cytokine levels to cell-cell or cell-matrix interactions. Previously, our lab found that TGF-β and IL-1 families cooperate to strongly induce MMP-9 gene expression in corneal epithelial cells (CECs). In this study, we investigate the intracellular signaling pathways mediating this induction.

Methods: : Primary cultures of Rabbit CECs, confirmed by immunostaining for cytokeratins 3/12, were used for all experiments. The CECs were co-transfected with an MMP-9 promoter-driven β-gal construct and an sv40 promoter-driven luciferase construct. The co-transfected cells were treated with TGF-β2 or IL-1β individually or in combination in the presence or absence of various pathway inhibitors (JSH-23, SB202190, PD98059, SIS3, and SP600125) for 24 hours. Cell lysates were harvested and β-Gal activity determined and normalized to luciferase activity.

Results: : Inhibition of the p38, NF-kB, or JNK pathways significantly reduced, but did not abrogate, basal MMP-9 promoter activity levels. Following TGF-β treatment, NF-kB, Smad3, or JNK inhibition significantly reduced MMP-9 promoter activity (p=0.002, 0.001, 0.009 respectively), whereas an effect on MMP-9 mediated reduction due to p38 inhibition was less significant (p=0.083). IL-1 mediated MMP-9 promoter activity was significantly reduced following NF-kB or p38 inhibition (p=0.014, 0.005 respectively), however, inhibition of Smad3 had a lower significant effect (p=0.051). Inhibition of the ERK pathway did not have an effect on MMP-9 mediated expression in either the treated or untreated co-transfected cells.

Conclusions: : Many signaling pathways are involved in the regulation of MMP-9 in CECs, most notably the NF-kB, p38 and JNK pathways. Our data suggest TGF-β mediated induction of MMP-9 promoter activity is regulated by the NF-kB, Smad3, and JNK pathways, whereas the IL-1β mediated induction may be regulated by the NF-kB and p38 pathways.

Keywords: cornea: epithelium • signal transduction • gene/expression 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.